Lung Diseases
Respiratory
3
Pipeline Programs
6
Companies
8
Clinical Trials
3 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
1
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
5 companies ranked by most advanced pipeline stage
M&
Alliance PharmaceuticalsUK - Wiltshire
1 program1
Combination Treatment - Cohort 1Phase 11 trial
Active Trials
Eko DevicesCA - Emeryville
3 programsEko digital stethoscopesN/A1 trial
Eko digital stethoscopesN/A1 trial
Eko digital stethoscopesN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Merck & Co.MK-0873 2.5 mg
Merck & Co.Zepatier
Alliance PharmaceuticalsCombination Treatment - Cohort 1
Eko DevicesEko digital stethoscopes
Eko DevicesEko digital stethoscopes
Eko DevicesEko digital stethoscopes
AmbuBronchoscopy
XVIVOhemodiafiltration
Clinical Trials (8)
Total enrollment: 1,829 patients across 8 trials
An Investigational Drug Study In Patients With COPD (Chronic Obstructive Pulmonary Disease) (MK-0873-005)
Start: Jun 2004Est. completion: Aug 2005604 patients
Phase 2Terminated
Transplanting Hepatitis C Lungs Into Negative Lung Recipients
Start: Dec 2018Est. completion: Dec 202210 patients
Phase 1/2Completed
Combination Paclitaxel, Carboplatin and Temozolomide
Start: Nov 2003Est. completion: Mar 201115 patients
Phase 1Completed
Data Collection Using Eko Devices in a Clinical Setting
Start: Oct 2025Est. completion: Dec 2026200 patients
N/ARecruiting
Data Collection Using Eko Digital Devices in a Clinical Setting
Start: Sep 2025Est. completion: Jul 2026250 patients
N/ARecruiting
Data Collection For Adventitious Lung Sounds Algorithm Using Eko Digital Devices in a Clinical Setting
Start: Aug 2024Est. completion: Mar 2026750 patients
N/AActive Not Recruiting
Observational Bronchoscopy Video Data Collection Study With Adult Patients
Start: Nov 2023Est. completion: Feb 2024
N/ACompleted
Evaluating the Addition of Hemodiafiltration to EVLP - Impact on the Regeneration of Marginal Donor Lungs
Start: Sep 2022Est. completion: Dec 2025
N/ARecruiting
Related Jobs in Respiratory
Ausbildung zum Pharmakanten (m/w/d)
Ferring Pharmaceuticals
Kiel, Germany
20h ago
Global Senior Medical Director – Respiratory Pipeline Medical Lead
Pfizer
United States - New York - New York City
Yesterday
$275K - $458K/yr
Praktikant (m/w/d) Marketing Onkologie
Amgen
Germany - Munich
Yesterday
Sr Product Manager, Monarch (1 of 2)
Johnson & Johnson
Santa Clara, California, United States of America
Yesterday
$142K - $245K/yr
Laboratory Assistant (m/w/d)
Ferring Pharmaceuticals
Kiel, Germany
Yesterday
Director Quality Control (m/w/d)
Ferring Pharmaceuticals
Kiel, Germany
Yesterday
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 actively recruiting trials targeting 1,829 patients
6 companies competing in this space